Verano Holdings (VRNO) Accumulated Expenses (2021 - 2026)
Verano Holdings (VRNO) reported Accumulated Expenses of $55.5 million for Q1 2026, down 5.08% year-over-year from $58.5 million in Q1 2025, and down 19.93% quarter-over-quarter from $69.3 million in Q4 2025.
Verano Holdings (VRNO) Accumulated Expenses (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Accumulated Expenses data on file, last reported at $55.5 million in Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $55.5 million, down 5.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.5 million (down 5.08% YoY), and the FY2025 annual result was $69.3 million, up 0.52% from the prior year.
- Accumulated Expenses slipped to $55.5 million in Q1 2026 per VRNO's latest filing, from $69.3 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $71.8 million in Q3 2025 and troughed at $30.8 million in Q2 2022.
- A 5-year average of $56.1 million and a median of $59.9 million in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2025: Accumulated Expenses soared 74.43% in 2023, then slipped 6.49% in 2025.
- A 5-year view of Accumulated Expenses shows it stood at $41.8 million in 2022, then jumped by 59.87% to $66.8 million in 2023, then increased by 3.26% to $68.9 million in 2024, then grew by 0.52% to $69.3 million in 2025, then dropped by 19.93% to $55.5 million in 2026.
- Business Quant data shows VRNO's Accumulated Expenses at $55.5 million in Q1 2026, $69.3 million in Q4 2025, and $71.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.49 Mn |
| Dec 31, 2025 | 69.30 Mn |
| Sep 30, 2025 | 71.76 Mn |
| Jun 30, 2025 | 61.51 Mn |
| Mar 31, 2025 | 58.46 Mn |
| Dec 31, 2024 | 68.94 Mn |
| Sep 30, 2024 | 69.92 Mn |
| Jun 30, 2024 | 65.78 Mn |
| Mar 31, 2024 | 61.30 Mn |
| Dec 31, 2023 | 66.77 Mn |
| Sep 30, 2023 | 52.11 Mn |
| Jun 30, 2023 | 53.68 Mn |
| Mar 31, 2023 | 37.91 Mn |
| Dec 31, 2022 | 41.76 Mn |
| Sep 30, 2022 | 32.05 Mn |
| Jun 30, 2022 | 30.77 Mn |
| Dec 31, 2021 | 42.15 Mn |